The effect of spinal manipulation on lung function in asymptomatic people with a history of respiratory disease
Not Applicable
Completed
- Conditions
- ung function in individuals 'at risk' of developing chronic obstructive pulmonary disease (COPD stage 0)Lung function in individuals 'at risk' of developing chronic obstructive pulmonary disease (COPD stage 0)Respiratory - Chronic obstructive pulmonary disease
- Registration Number
- ACTRN12608000518369
- Lead Sponsor
- Roger Engel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
History of respiratory disease
Below normal spirometry
Ambulatory
Exclusion Criteria
Current respiratory disease
Non-ambulatory
Contra-indicated to spinal manipulation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome 1: spirometry measurements of forced vital capacity (FVC) & forced expiratory volume in 1st second (FEV1)[Timepoints: pre and post intervention session i.e 3 x week over 3 weeks];Primary outcome 2: respiratory inductive plethysmography[Timepoints: pre and post intervention session i.e 3 x week over 3 weeks]
- Secondary Outcome Measures
Name Time Method Total change in lung function via spirometry (initial and final FVC & FEV1)[at initial and final interventions and 3 weeks post intervention i.e. 6 weeks after initial intervention]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link spinal manipulation to improved lung function in COPD stage 0 individuals?
How does spinal manipulation compare to standard pulmonary rehabilitation in early COPD intervention?
Are there specific biomarkers that predict lung function improvement from spinal manipulation in COPD stage 0?
What adverse events are associated with spinal manipulation for COPD stage 0 and how are they managed?
What combination therapies show synergistic effects with spinal manipulation for COPD stage 0 prevention?